Prospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Jun 6, 2019; 7(11): 1291-1301
Published online Jun 6, 2019. doi: 10.12998/wjcc.v7.i11.1291
Table 2 Comparison of APACHE II score, SOFA score, Hs-TnI, NT-proBNP, PaO2/FiO2 and Lac on day 1, 3 and 7 after treatment between PiCCO and control groups
GroupNo.Treatment timeAPACHE II scoreSOFA scoreHs-TnI (ng/mL)NT-proBNP (pg/ml)PaO2/FiO2 (mmHg)Lac (mmol/L)
Control group301 d25.03 ± 7.3511.31 ± 3.570.54 ± 0.3313781.31 ± 9508.70260.32 ± 111.502.41 ± 1.17
3 d22.00 ± 5.619.00 ± 3.390.40 ± 0.3511537.69 ± 9701.62294.94 ± 102.802.30 ± 1.03
7 d17.57 ± 4.897.09 ± 3.340.33 ± 0.289083.04 ± 7702.01341.10 ± 98.051.99 ± 0.70
PiCCO Group301 d21.10 ± 5.95a8.37 ± 3.44b0.34 ± 0.25a8947.00 ± 5739.86a284.05 ± 127.062.15 ± 1.13
3 d17.52 ± 4.88b6.38 ± 3.05b0.17 ± 0.24b7294.83 ± 3638.23a346.96 ± 108.391.80 ± 0.95
7 d11.89 ± 3.38b4.07 ± 2.02b0.11 ± 0.14b5939.14 ± 2396.84a395.36 ± 88.20a1.52 ± 0.74a